Newsfeeds - Spark Newswire

2 minute read

News

Epizyme 8-K Shows Co. Received Written Notice From Glaxo Group GSK Elected To Terminate Collab, License Deal With Epizyme

Today, 1:42 PM

On December 16, 2021, Epizyme, Inc. (the “Company”) received written notice from Glaxo Group Limited (“GSK”) that GSK has elected to terminate the Collaboration and License Agreement dated

EPZM

1 minute read

‘In @WHCOVIDResponse briefing, Zients gives update on supply in what he calls the nation’s medicine cabinet for #covid19. In Jan.: 265K courses of Pfizer drug, 3M of Merck drug (if authorized), 500K+ of AZN preventive antibody, 300K of Vir/GSK antibody…

By Benzinga Newsdesk

Today, 1:42 PM

https://twitter.com/megtirrell/status/1473750991296208909

AZN

2 minute read

Ligand And GSK Expand Global Collaboration And License Agreement; Ligand To Receive An Upfront Payment Of $10M And Is Eligible For Development And Regulatory Milestones Up To $67.5M

By Benzinga Newsdesk

Today, 1:42 PM

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced today the expansion of an existing collaboration and license agreement between its subsidiary, Icagen, and GlaxoSmithKline (GSK). The expansion will leverage

GSK

4 minute read

The Daily Biotech Pulse: Aldeyra Sinks On Dry Eye Disease Readout, Sanofi Goes Shopping, Regulatory Setback For Aquestive, Aridis Touts Pan-Coronavirus Antibody Cocktail

By Shanthi Rexaline

Today, 1:42 PM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ABBV

1 minute read

Long-Acting HIV Treatment Backed By GSK, Pfizer Scores FDA Approval As Preventative Option

By Vandana Singh

Today, 1:42 PM

The FDA has approved ViiV Healthcare’s Apretude, the first and only long-acting injectable pre-exposure prophylaxis (PrEP) option, to reduce the risk…

GSK

1 minute read

FDA Approves GlaxoSmithKline’s Injectable Treatment for HIV Pre-Exposure Prevention

By Benzinga Newsdesk

Today, 1:42 PM

-Reuters

GSK

1 minute read

Glaxo-Vir Biotech’s Antibody Approved In Europe For Early Treatment Of COVID-19

By Vandana Singh

Today, 1:42 PM

The

GSK

1 minute read

Why Are Vir Biotech Shares Gaining Today?

By Vandana Singh

Today, 1:42 PM

Vir Biotechnology Inc (NASDAQ: VIR) announced

GSK

1 minute read

News

Sanofi, GlaxoSmithKline Said They Expect Data from Late-stage Clinical Trials of its Booster Dose of Their Covid-19 Vaccine Candidate in Q1 2022 vs Late 2021

By Charles Gross

Today, 1:42 PM

-Reuters https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-gsk-announce-positive-booster-data-their-covid-19-vaccine-candidate-2021-12-15/

GSK